Yuichiro et al. (Itoh et al., 2019) found that a KDM6A deletion mutation resulted in the activation of Th1 and Th2 cell pathways and the down regulation of an inflammatory response in CD4+ T cells, which is likely to contribute to a pro-tumor microenvironment. Here, CD4 is linked to neoplasm.